Compare CPB & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPB | CRL |
|---|---|---|
| Founded | 1869 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 8.0B |
| IPO Year | N/A | 2000 |
| Metric | CPB | CRL |
|---|---|---|
| Price | $30.68 | $177.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 15 |
| Target Price | $34.20 | ★ $190.15 |
| AVG Volume (30 Days) | ★ 5.5M | 1.1M |
| Earning Date | 12-09-2025 | 11-05-2025 |
| Dividend Yield | ★ 5.10% | N/A |
| EPS Growth | ★ 6.35 | N/A |
| EPS | ★ 2.01 | N/A |
| Revenue | ★ $10,253,000,000.00 | $4,023,704,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.15 | $2.43 |
| P/E Ratio | $15.22 | ★ N/A |
| Revenue Growth | ★ 6.40 | N/A |
| 52 Week Low | $29.39 | $91.86 |
| 52 Week High | $46.36 | $203.01 |
| Indicator | CPB | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 48.03 | 55.87 |
| Support Level | $30.00 | $157.49 |
| Resistance Level | $32.04 | $179.19 |
| Average True Range (ATR) | 0.71 | 5.72 |
| MACD | -0.02 | 1.21 |
| Stochastic Oscillator | 30.64 | 82.93 |
Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Outside its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and recently acquired Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.